OverviewChartProfileKey statisticsFinancialsTechnicalNews
Derivatives
TraderScreen

Check Point Software Technologies.../  IL0010824113  /

NASDAQ
2024-04-19  10:00:00 PM Chg. -0.4300 Volume Bid11:37:20 PM Ask11:37:20 PM Market Capitalization Dividend Y. P/E Ratio
157.9500USD -0.27% 668,123
Turnover: 71.5 mill.		 152.0800Bid Size: 100 162.3300Ask Size: 100 18.47 bill.USD - 21.97
GlobeNewswire 04-19 Nykode Therapeutics Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical Cancer
GlobeNewswire 04-18 ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Couns...
GlobeNewswire 04-17 SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
GlobeNewswire 04-17 Enterome Announces Successful Completion of Phase 2 ROSALIE Study of EO2401 in Recurrent Glioblastom...
GlobeNewswire 04-17 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ven...
GlobeNewswire 04-16 INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. wit...
GlobeNewswire 04-16 OSE Immunotherapeutics’ Global License to Develop a Novel Monoclonal Antibody for the Treatment of C...
GlobeNewswire 04-16 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Checkp...
GlobeNewswire 04-16 Compass Therapeutics Announces First Patient Dosed in the Phase 1 Study of CTX-8371 in Patients with...
GlobeNewswire 04-15 CKPT Class Action Alert: Robbins LLP Reminds Stockholders of Checkpoint Therapeutics, Inc. Class Act...
GlobeNewswire 04-15 DEADLINE ALERT for HRT, CKPT, and SOND: The Law Offices of Frank R. Cruz Reminds Investors of Class ...
GlobeNewswire 04-15 CKPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Checkpoint Therapeutics, Inc. ...
GlobeNewswire 04-13 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ven...
GlobeNewswire 04-12 SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
GlobeNewswire 04-12 ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Couns...
GlobeNewswire 04-11 Check Point Software Technologies Transforms Email Security Again: Patented Unified Administration B...
GlobeNewswire 04-10 Checkpoint Therapeutics, Inc. investors: Please contact the Portnoy Law Firm to recover your losses;...
GlobeNewswire 04-10 SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. ...
GlobeNewswire 04-10 Medicenna Presents Updated Results of Single Agent MDNA11 Anti-tumor Activity from Dose Escalation a...
GlobeNewswire 04-10 TILT Biotherapeutics Presents Clinical Data on TILT-123 in Combination with KEYTRUDA® (pembrolizumab...
GlobeNewswire 04-09 ALX Oncology Reports Encouraging Clinical Data of Evorpacept in Combination with Standard-of-Care in...
GlobeNewswire 04-09 CKPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Checkpoint Therapeutics, Inc. ...
GlobeNewswire 04-09 Medicenna Presents Updated Results of Single Agent MDNA11 Anti-tumor Activity from Dose Escalation a...
GlobeNewswire 04-09 Frontier Medicines Presents New Data for First-In-Class Dual ON+OFF KRAS G12C Inhibitor FMC-376 at t...
GlobeNewswire 04-09 Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer...